Cyramza
Payments companies reported to CMS as associated with Cyramza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cyramza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cyramza
These are the largest totals companies reported as associated with Cyramza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Treat | Philadelphia, PA | Medical Oncology | $15,843.13 |
| Sandeep Kodityal | Shenandoah, TX | Hematology & Oncology | $5,648.31 |
| Ahmed Zakari | Altamonte Springs, FL | Hematology (Internal Medicine) | $1,437.50 |
| Benjamin Weinberg | Washington, DC | Hematology & Oncology | $425.00 |
| Asna Shilleh | Los Angeles, CA | Family | $113.15 |
| Mia Wong | Los Angeles, CA | Nurse Practitioner | $113.15 |
| Federico Albrecht | Miami, FL | Hematology & Oncology | $112.14 |
| Tarek Mekhail | Orlando, FL | Hematology & Oncology | $106.13 |
| Lindsey Kulbacki | Appleton, WI | Physician Assistant | $91.92 |
| Daisy Boehm | Appleton, WI | Family | $91.92 |
Prescribed Cyramza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.